Federal Register - August 24, 2021
Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.
Source: Federal Register
47314
Federal Register / Vol. 86, No. 161 / Tuesday, August 24, 2021 / Notices
The total burden is estimated to be 235.5 hours.
Exhibit 2 shows the estimated annualized cost burden based on the respondents time to submit their data.
The cost burden is estimated to be $12,312 annually.
EXHIBIT 1ESTIMATED ANNUALIZED BURDEN HOURS
Number of respondents/
POCs
Form name
Number of responses per POC
Hours per response
Total burden hours
Eligibility/Registration Form
Data Use Agreement
Medical Office Information Form
Data Files Submission
85
85
85
85
1
1
20
1
3/60
3/60
5/60
1
4.25
4.25
142
85
Total
NA
NA
NA
235.5
EXHIBIT 2ESTIMATED ANNUALIZED COST BURDEN
Number of respondents/
POCs
Form name
Total burden hours
Average hourly wage rate
Total cost burden
Registration Form
Data Use Agreement
Medical Office Information Form
Data Files Submission
85
85
85
85
4.25
4.25
142
85
$52.28
52.28
52.28
52.28
$222
222
7,424
4,444
Total
NA
235.5
NA
12,312
Mean hourly wage rate of $52.28 for Medical and Health Services Managers SOC code 119111 was obtained from the May 2019 National Industry-Specific Occupational Employment and Wage Estimates, NAICS 621100Offices of Physicians located at https www.bls.gov/oes/current/naics4_621100.htm.
lotter on DSK11XQN23PROD with NOTICES1
Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQs information collection are requested with regard to any of the following: a Whether the proposed collection of information is necessary for the proper performance of AHRQs health care research and health care information dissemination functions, including whether the information will have practical utility; b the accuracy of AHRQs estimate of burden including hours and costs of the proposed collections of information; c ways to enhance the quality, utility and clarity of the information to be collected; and d ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized and included in the Agencys subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record.
Dated: August 18, 2021.
Marquita Cullom, Associate Director.
FR Doc. 202118126 Filed 82321; 8:45 am BILLING CODE 416090P
VerDate Sep<11>2014
16:43 Aug 23, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration Docket No. FDA2021N0856
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a public docket; request for comments.
ACTION:
The Food and Drug Administration FDA or Agency announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee VRBPAC. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. Members will participate via teleconference. At least one portion of the meeting will be closed to the public.
FDA is establishing a docket for public comment on this document.
DATES: The meeting will be held on September 30, 2021, from 8:30 a.m. to 3:40 p.m. Eastern Time.
ADDRESSES: Please note that due to the impact of this COVID19 pandemic, all meeting participants will be joining this advisory committee meeting via an SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
online teleconferencing platform. The online web conference meeting will be available at the following link on the day of the meeting: https youtu.be/
VeknygU5MKM.
FDA is establishing a docket for public comment on this meeting. The docket number is FDA2021N0856.
The docket will close on September 29, 2021. Submit either electronic or written comments on this public meeting by September 29, 2021. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before September 29, 2021. The https
www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of September 29, 2021. Comments received by mail/hand delivery/courier for written/paper submissions will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.
Comments received on or before September 23, 2021, will be provided to the committee. Comments received after September 23, 2021, and by September 29, 2021, will be taken into consideration by FDA. In the event that the meeting is canceled, FDA will continue to evaluate any relevant applications or information, and consider any comments submitted to the docket, as appropriate.
E:FRFM24AUN1.SGM
24AUN1
